Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Terminated 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Neoplasm Metastasis 3Carcinoma, Hepatocellular 3Thyroid Nodule 2Lung Neoplasms 2Liver Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Osteosarcoma 1Leiomyoma 1Hyperthyroidism 1Fibrosis 1Esophageal Squamous Cell Neoplasia (ESCN) 1Carcinoma, Renal Cell 1Breast Neoplasms 1Barrett Esophagus 1

Interventions

Sorafenib 3vandetanib 2alectinib 2Sodium 2Magnetic Resonance Spectroscopy 2Imatinib Mesylate 2Bevacizumab 2tremelimumab 1temsirolimus 1ponatinib 1perflutren 1pembrolizumab 1methyl N-acetylsibirosaminide 1lenvatinib 1gallium 68 PSMA-11 1fosbretabulin 1durvalumab 1combretastatin 1cobimetinib 1cabozantinib 1X-Rays 1Valproic Acid 1Thyroxine 1Technetium Tc 99m Sestamibi 1Sirolimus 1Radiofrequency Ablation 1Presenilin-1 1Paclitaxel 1PLX8394 1Lubricant Eye Drops 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Thyroid Neoplasms × Radiofrequency Ablation × Clear all
NCT05003856 2025-04-02

Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule

M.D. Anderson Cancer Center

Phase NA Terminated
1 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Thyroid Nodule

Data powered by HemOnc (CC BY 4.0) Colophon âš¡